(NYSE: WST) West Pharmaceutical Services's forecast annual revenue growth rate of 5.73% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.85%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.03%.
West Pharmaceutical Services's revenue in 2024 is $2,928,600,000.On average, 4 Wall Street analysts forecast WST's revenue for 2024 to be $219,437,679,481, with the lowest WST revenue forecast at $219,204,144,320, and the highest WST revenue forecast at $219,949,912,562. On average, 4 Wall Street analysts forecast WST's revenue for 2025 to be $238,810,244,242, with the lowest WST revenue forecast at $237,369,479,440, and the highest WST revenue forecast at $242,130,653,868.
In 2026, WST is forecast to generate $257,102,180,769 in revenue, with the lowest revenue forecast at $253,061,716,537 and the highest revenue forecast at $264,617,336,434.